This free case-based course focuses on a 63-year-old man who presents with castration-resistant prostate cancer (CRPC), highlighting issues related to risk factors, molecular progression of the disease, and treatment options.
- Enhance awareness of the relevance of androgens in castration-resistant prostate cancer (CRPC).
- Improve understanding of mechanisms of androgen resistance in CRPC.
- Identify and utilize appropriate new therapeutic modalities for the treatment of CRPC.
ACGME Competencies addressed: Medical Knowledge; Practice-based Learning & Improvement
Note: This course is now accessible through iPads as well as personal computers